英国停止择期服务前髋膝关节置换术后COVID-19发生率与相关死亡率
这项多中心回顾性研究分析了2020年3月英国1,073例髋膝关节置换患者,术后SARS-CoV-2阳性率为0.5%,校正混杂因素后住院时间延长与术后COVID-19独立相关,COVID-19归因死亡率为0.09%,但感染者死亡率为20%。
要点
- 术后COVID-19阳性率为0.5%,考虑未就诊者可能高达1%。
- 住院时间延长是术后COVID-19唯一显著相关因素,>3天预测AUC为81%。
- COVID-19感染者死亡率为20%,但总体COVID-19归因死亡率仅0.09%。
核心结论
- 髋膝关节置换术后COVID-19发生率为0.5%,考虑未就诊患者可能高达1%,与同期人群患病率估计相似。
- COVID-19归因总体死亡率低(0.09%),但感染者死亡率达20%。
研究设计与样本
- 多中心回顾性研究,纳入2020年3月1日至31日英国接受髋或膝关节置换的患者,随访至少60天。
- 共1,073例患者,记录人口学、ASA分级、手术类型、初次或翻修、住院时间、COVID-19检测状态及术后死亡率。
- 对211例出院后未就诊患者进行电话随访,询问COVID-19症状。
主要发现
- 1,073例中5例(0.5%)术后SARS-CoV-2检测阳性。
- 校正混杂因素后,住院时间延长是术后COVID-19唯一显著相关因素(p=0.022),住院>3天预测AUC为81%(p=0.018)。
- 研究队列共3例(0.3%)死亡,COVID-19归因总体死亡率为0.09%(1/1,073),5例COVID-19患者中1例(20%)死亡。
- 211例 contacted 患者中2例术后2至14天出现症状,阳性预测值31%,估计1例可能为未诊断COVID-19。
关键数值与推荐
- 术后COVID-19发生率0.5%(5/1,073),考虑未就诊者可能高达1%。
- COVID-19归因死亡率0.09%(1/1,073),感染者死亡率20%(1/5)。
- 住院时间延长与术后COVID-19相关(p=0.022),住院>3天预测AUC 81%(p=0.018)。
临床怎么用
- 择期髋膝关节置换术前应评估并尽量缩短住院时间,住院>3天与术后COVID-19风险升高相关。
- 术后COVID-19总体死亡率低,但一旦感染死亡风险达20%,需重视围手术期感染防控。
局限性
- 回顾性多中心设计,仅纳入2020年3月单月手术患者。
- 仅对211例未就诊患者进行电话随访,未就诊者COVID-19发生率可能被低估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The primary aim was to assess the rate of postoperative COVID-19 following hip and knee arthroplasty performed in March 2020 in the UK. The secondary aims were to assess whether there were clinical factors associated with COVID-19 status, the mortality rate of patients with COVID-19, and the rate of potential COVID-19 in patients not presenting to healthcare services. METHODS: A multicentre retrospective study was conducted of patients undergoing hip or knee arthroplasty during the first wave of the COVID-19 pandemic (1 March 2020 to 31 March 2020) with a minimum of 60 days follow-up. Patient demographics, American Society of Anesthesiologists grade, procedure type, primary or revision, length of stay (LOS), COVID-19 test status, and postoperative mortality were recorded. A subgroup of patients (n = 211) who had not presented to healthcare services after discharge were contacted and questioned as to whether they had symptoms of COVID-19. RESULTS: Five (0.5%) of 1,073 patients who underwent hip or knee arthroplasty tested positive for SARS-CoV-2 postoperatively. When adjusting for confounding factors, increasing LOS (p = 0.022) was the only significant factor associated with developing COVID-19 following surgery and a stay greater than three days was a reliable predictor with an area under the curve of 81% (p = 0.018). There were three (0.3%) deaths in the study cohort and the overall mortality rate attributable to COVID-19 was 0.09% (n = 1/1,073), with one (20%) of the five patients with COVID-19 dying postoperatively. Of the 211 patients contacted, two had symptoms within two to 14 days postoperatively with a positive predictive value of 31% and it was therefore estimated that one patient may have had undiagnosed COVID-19. CONCLUSION: The rate of postoperative COVID-19 was 0.5% and may have been as high as 1% when accounting for those patients not presenting to healthcare services, which was similar to the estimated population prevalence during the study period. The overall mortality rate secondary to COVID-19 was low (0.09%), however the mortality rate for those patients developing COVID-19 was 20%. Cite this article: Bone Joint J 2021;103-B(4):681-688.
引用
- Clement ND, Hall AJ, Kader N, et al. The rate of COVID-19 and associated mortality after elective hip and knee arthroplasty prior to cessation of elective services in UK. Bone Joint J. 2021. PMID: 33591211. doi:10.1302/0301-620X.103B.BJJ-2020-1776.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。